High Tech Pharm Co., Ltd. (KOSDAQ:106190)

South Korea flag South Korea · Delayed Price · Currency is KRW
15,700
+570 (3.77%)
At close: Mar 6, 2026
-0.57%
Market Cap 154.18B
Revenue (ttm) 75.60B
Net Income (ttm) 11.98B
Shares Out 10.63M
EPS (ttm) 1,122.62
PE Ratio 12.92
Forward PE n/a
Dividend 150.00 (0.96%)
Ex-Dividend Date Dec 29, 2025
Volume 34,851
Average Volume 61,870
Open 15,050
Previous Close 15,130
Day's Range 14,800 - 15,750
52-Week Range 10,700 - 17,800
Beta 0.61
RSI 59.23
Earnings Date Apr 1, 2026

About High Tech Pharm

High Tech Pharm Co., Ltd. researches and develops, manufactures, and sells injectable carbapenem-based antibiotics worldwide. The company was incorporated in 1998 and is based in Chungju-si, South Korea. [Read more]

Industry Pharmaceutical Preparations
Founded 1998
Employees 65
Stock Exchange KOSDAQ
Ticker Symbol 106190
Full Company Profile

Financial Performance

In 2024, High Tech Pharm's revenue was 77.51 billion, an increase of 0.97% compared to the previous year's 76.77 billion. Earnings were 13.71 billion, an increase of 69.75%.

Financial Statements

News

There is no news available yet.